财经快讯|丽珠集团:公司持续推进新冠疫苗研发,针对XBB、BQ.1组合的多价苗在小鼠实验取得良好结果
丽珠集团近期接受投资者调研时称,目前,公司仍持续推进新冠疫苗的研发,将主流流行株作为跟踪重点,利用疫苗平台技术开发多价苗。针对XBB、BQ.1组合的多价苗,在小鼠实验取得良好结果,已向CDE递交沟通交流,争取获批后开展临床试验。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!